October 15, 2024 – Notice of Funding Opportunity (NOFO) New Therapeutic Strategies for Genital Herpes
The purpose of this notice of funding opportunity (NOFO) is to stimulate the development of new treatments for genital herpes that suppress shedding and lesion formation and reduce transmission. This NOFO invites applications that propose research into a broad range of therapeutic approaches, including but not limited to development of new or improved antivirals, monoclonal antibodies, therapeutic vaccines, and gene editing technologies for treatment of people living with genital herpes.
This NOFO will use a milestone-driven, phased innovation award. Transition to the second phase is not guaranteed and will depend on the successful completion of milestones.
NIAID intends to commit $3.5 million in FY 2026 to fund 7-10 awards.
Learn more and apply!
Give Today and Join the Fight →
Every donation – whether $10 or $10,000 – moves us closer to a world where herpes is effectively treated and free from stigma.
Questions about giving? Contact us at info@herpescureadvocacy.com or 267-797-7139.
Want the latest news on herpes cure, treatment and prevention?
Sign up for our newsletter and make sure you never miss a thing.
